Ann: Canine Cancer Trial Update, page-70

I've addressed this issue before, too, @adreamer.

It seems today's theme is "Hits and memories". Tiresome.

The point you've raised is correct - they were actually inelligible to apply because they did not possess sufficient cGMP drug for a trial.

There's also the small issue of no/inadequate PK data and an undefined MOA.

The WEHI, 360 Biolabs and Leiden data is all 'promising' but inadequate as the basis for a human clinical trial.

Once we have the safety and PK from the GRANT FUNDED MND TRIAL, we'll be in a much better position to progress with human clinical trials in other indications. Like, for instance, COVID-19 and human cancers.

Wait a minute.... I've heard this somewhere before.

Cheers

Densy